Menü
sharewise zieht um Am Wochenende vom 22./23. August wird das neue sharewise die Hauptseite. Schau es dir jetzt an und sag uns, was dir fehlt. Zum neuen sharewise Was sich ändert
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Where Will Ocugen Be in 3 Years?


Over the last three years, Ocugen's (NASDAQ: OCGN) stock has lost 60% of its value, frustrating the small biotech's early investors. But if its gains of more than 4,700% in the last 12 months are to be believed, the market is quite enthusiastic about the company's potential. This is likely thanks to its externally developed coronavirus vaccine, which might be approved for sale sometime next year.

Will its vaccine lift it to new heights by the end of 2024, or is Ocugen's time in the limelight approaching an end now that its competitors are so far ahead?

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Teilen

Kommentare